Cost and effectiveness of chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners

Sexually Transmitted Diseases

Volumn 35, Issue 8, 2008, Pages 705-713

  Nevin, Remington L ^a   Shuping, Eric E ^b   Frick, Kevin D ^c   Gaydos, Joel C ^d   Gaydos, Charlotte A ^e  

^a Army Medical Surveillance Activity   (United States)

^b Ireland Army Community Hospital   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Defense Global Emerging Infections Surveillance and Response System ^*  (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARMY; ARTICLE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MATHEMATICAL ANALYSIS; MATHEMATICAL AND STATISTICAL PROCEDURES; MATHEMATICAL COMPUTING; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; POLICY; PROBABILITY; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; CONTACT EXAMINATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; DECISION TREE; ECONOMICS; FEMALE; SOLDIER; UNITED STATES;

CHLAMYDIA INFECTIONS; CONTACT TRACING; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION TREES; DIRECT SERVICE COSTS; FEMALE; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; MILITARY PERSONNEL; PELVIC INFLAMMATORY DISEASE; UNITED STATES;

EID: 54749114062     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31816d1f55     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillace 2005. Available at: http://www.cdc.gov/std/stats/ chlamydia.htm. Accessed August 22, 2007.
2. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147:89-96.
3. Gaydos CA, Howell MR, Quinn TC, et al. Sustained high prevalence of Chlamydia trachomatis infections in female army recruits. Sex Transm Dis 2003; 30:539-544.
4. Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male army recruits. J Infect Dis 2001; 184:1216-1219.
5. Rein DB, Kassler WJ, Irwin KL, et al. Direct medical cost of pelvic inflammatory disease and its sequelae: Decreasing, but still substantial. Obstet Gynecol 2000; 95:397-402.
6. Horsburgh CR Jr, Douglas JM, LaForce FM. Preventive strategies in sexually transmitted diseases for the primary care physician. US Preventive Services Task Force. JAMA 1987; 258:814-821.
7. US Preventive Services Task Force. Screening for chlamydial infection: Recommendations and rationale. Am J Prev Med 2001; 20(3 suppl):90-94.
8. US Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 147:128 -134.
9. Howell MR, Gaydos JC, McKee KT Jr, et al. Control of Chlamydia trachomatis infections in female army recruits: Cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999; 26:519 -526.
10. Department of Defense. Population Representation in the Military Services: Fiscal Year 2002; 29th Annual Department of Defense (DoD) Report on Social Representation in the U.S. Military Services. Accessed August 26, 2007.
11. Gaydos CA. Nucleic acid amplification tests for gonorrhea and chlamydia: Practice and applications. Infect Dis Clin North Am 2005; 18:55-66.
12. Blake DR, Gaydos CA, Quinn TC. Cost-effectiveness analysis of screening adolescent males for chlamydia on admission to detention. Sex Transm Dis 2004; 31:85-95.
13. Gift TL, Lincoln T, Tuthill R, et al. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis 2006; 33(10 suppl):S103-S110.
14. Roberts TE, Robinson S, Barton P, et al. Screening for Chlamydia trachomatis: A systematic review of the economic evaluations and modeling. Sex Transm Infect 2006; 82:193-200.
15. Welte R, Postma M, Leidl R, et al. Costs and effects of chlamydial screening: Dynamic versus static modeling. Sex Transm Dis 2005; 32:474-483.
16. de Vries R, van Bergen JE, de Jong-van den Berg, et al. Systematic screening for Chlamydia trachomatis: Estimating cost-effectiveness using dynamic modeling and Dutch data. Value Health 2006; 9:1-11.
17. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Columbian women: A 5-year follow-up study. J Infect Dis 2005; 191:907-916.
18. Morre SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13(suppl 2):12-18.
19. Smith KJ, Ness RB, Roberts MS. Hospitalization for pelvic inflammatory disease: A cost-effectiveness analysis. Sex Transm Dis 2007; 34:108-112.
20. Hu D, Hook EW, Goldie SJ. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006; 33:428-436.
21. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32:778-784.
22. Hu D, Hook EW III, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis. Ann Intern Med 2004; 141:501-513.
23. Sutton TL, Martinko T, Hale S, et al. Prevalence and high rate of asymptomatic infection of Chlamydia trachomatis in male college Reserve Officer Training Corps cadets. Sex Transm Dis 2003; 30: 901-904.
24. Zimmerman-Rogers H, Potterat JJ, Muth SQ, et al. Establishing efficient partner notification periods for patients with chlamydia. Sex Transm Dis 1999; 26:49-54.
25. Low N, McCarthy A, Roberts TE, et al. Partner notification of chla-mydia infection in primary care: Randomised controlled trial and analysis of resource use. BMJ 2006; 332:14 -19.
26. Tao G, Tian LH, Peterman TA. Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States. Sex Transm Dis 2007; 34:180-182.
27. Joesoef MR, Mosure DJ. Prevalence trends in chlamydial infections among young women entering the national job training program, 1998-2004. Sex Transm Dis 2006; 33:571-575.
28. Yeh JM, Hook EW, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003; 30:369-378.
29. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
30. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: A meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29:497-502.
31. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998; 128:277-284.
32. Howell MR, Quinn TC, Brathwaite W, et al. Screening for Chlamydia trachomatis in family planning clinics. Sex Transm Dis 1998; 25:274-280.
33. Arcari CM, Gaydos JC, Howell MR, et al. Feasibility and short-term impact of linked education and urine screening interventions for Chlamydia and gonorrhea in male army recruits. Sex Transm Dis 2004; 31:443-447.
34. Silva A, Glick NR, Lyss SB, et al. Implementing an HIV and sexually transmitted disease screening program in an emergency department. Ann Emerg Med 2007 ; 49:564-572.
35. Tao G, Abban BK, Gift TL, et al. Applying a mixed-integer program to model re-screening women who test positive for C. trachomatis infection. Health Care Manag Sci 2004; 7:135-144.
36. Gift TL, Hogben M. Emergency department sexually transmitted disease and human immunodeficiency virus screening: Findings from a national survey. Acad Emerg Med 2006; 13:993-996.
37. Duncan B, Hart G. Sexuality and health: The hidden costs of screening for Chlamydia trachomatis. BMJ 1999; 318:931-933.
38. Wang LY, Burstein GR, Cohen DA. An economic evaluation of a school-based sexually transmitted disease screening program. Sex Transm Dis 2002; 29:737-745.
39. Ginocchio RH, Veenstra DL, Connell FA, et al. The clinical and economic consequences of screening young men for genital chlamydial infection. Sex Transm Dis 2003; 30:99-106.
40. Marrazzo JM, Ellen JM, Kent C, et al. Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers. Sex Transm Dis 2007; 34:147-153.